Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.12 | €2.40 | 114.477% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 0 | 0 | €17.89 | €26.64 | 48.948% |
| Drägerwerk AG & Co. KGaA ST | 3 | 0 | 0 | 0 | €44.40 | €66.00 | 48.649% |
| Novo Nordisk A/S | 6 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Verastem Inc. | 14 | 0 | 0 | 0 | €2.20 | €16.16 | 634.605% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 0 | 0 | €2.35 | €4.62 | 96.492% |
| Abbott Laboratories | 20 | 0 | 0 | 0 | €103.88 | €116.25 | 11.906% |
| UCB S.A. | 1 | 0 | 0 | 0 | €160.65 | - | - |
| Cigna Corp. | 24 | 0 | 0 | 0 | €331.15 | €360.98 | 9.008% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €26.30 | €35.01 | 33.100% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 0 | 0 | €430.85 | €440.93 | 2.339% |
| Bausch Health Companies Inc. | 6 | 0 | 0 | 0 | €5.50 | €12.95 | 135.344% |
| Myriad Genetics | 4 | 3 | 0 | 0 | €25.20 | €22.15 | -12.113% |
| US Physical Therapy Inc. | 8 | 1 | 0 | 0 | €76.50 | €107.59 | 40.645% |
| Dynavax Technologies Corp | 4 | 0 | 0 | 0 | €10.18 | €26.95 | 164.862% |
| Edwards Lifesciences Corp. | 32 | 1 | 0 | 0 | €62.27 | €83.40 | 33.940% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.77 | - | - |
| Halozyme Therapeutics Inc. | 22 | 0 | 0 | 0 | €55.46 | €56.47 | 1.819% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €108.40 | €109.00 | 0.554% |
| Brookdale Sr Lvg | 5 | 1 | 0 | 0 | €6.40 | €8.27 | 29.206% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.03 | - | - |
| Insulet Corp. | 16 | 0 | 0 | 0 | €183.40 | €215.54 | 17.523% |
| Masimo Corp. | 7 | 1 | 0 | 0 | €106.20 | €151.02 | 42.208% |
| Smith & Nephew plc ADR | 3 | 0 | 0 | 0 | €27.40 | - | - |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |